Dräger, a global leader in medical technology, is making a big bet on emerging markets. Come learn how corporate investment in global health can unlock untapped market share and create outsized social impact. Dräger and their NGO partners will lead a deal clinic on how to navigate contracts between radically different types of partners, how to influence established commercial operations to (profitably) reach more underserved clients, and how to find common ground when pursuing radical collaborations.
Health Access and Big MedTech: How radical collaboration yields transformative results for health equity, inclusion, and market share; inside the Dräger deal book
Daniel Wald
July 13, 2022
Format
Workshop
Meta Themes
Deliver Equity and Inclusion
Reimagine Systems
Themes
Health Equity, MedTech, Global Health, Radical Collaboration
Purpose and Desired Outcome
Deeper understanding on the benefits of using nontraditional partnerships to achieve transformative social and financial success. More NGOs/non-profits should work with industry to scale; more industry should work with NGOs/non-profits to broaden their portfolio to reach more beneficiaries. Funders should actively sponsor radical collaboration to mainstream these types of partnerships.
Audiences
Corporate & SME
Allocators (Family Offices, HNW Individuals, Foundations)
Entrepreneurs
Accelerators & Incubators
Service Providers
Speakers
- NameStefanie Wagner
- TitleSenior Product Manager
- OrganizationDrägerwerk AG & Co. KGaA
- StatusInvited
- NameRasa Izadnegahdar
- TitleDirector, Maternal, Newborn & Child Health Discovery & Tools
- OrganizationBill & Melinda Gates Foundation
- StatusInvited
- NameTom Hansen
- TitleFormer CEO & Professor
- OrganizationSeattle Childrens Hospital
- StatusInvited
- NameDaniel Wald
- TitleCGO
- OrganizationEqualize Health
- StatusConfirmed
